NB02 (Poseltinib)

Poseltinib · NOBO Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NB02 (Poseltinib), covering 2024-12-17 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL [Phase 2]